Compared to Estimates, Zai Lab Limited (ZLAB) Q3 Earnings: A Look at Key Metrics

12.11.24 18:00 Uhr

Zai Lab Limited Unsponsored ADR (ZLAB) reported $102.27 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 47.7%. EPS of -$0.42 for the same period compares to -$0.71 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $102.55 million, representing a surprise of -0.27%. The company delivered an EPS surprise of +44.00%, with the consensus EPS estimate being -$0.75.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Zai Lab Limited performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Product Revenue- ZEJULA: $48.23 million versus the three-analyst average estimate of $46.10 million. Product Revenue- OPTUNE: $7.72 million versus the three-analyst average estimate of $9.52 million. Product Revenue- VYVGART: $27.27 million versus the three-analyst average estimate of $26.50 million. Product Revenue- NUZYRA: $10 million versus $12 million estimated by three analysts on average. Product Revenue- QINLOCK: $8.64 million versus $7.54 million estimated by three analysts on average. View all Key Company Metrics for Zai Lab Limited here>>>Shares of Zai Lab Limited have returned +25.8% over the past month versus the Zacks S&P 500 composite's +3.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Zai Lab Limited Unsponsored ADR (ZLAB): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Zai Lab

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Zai Lab

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Zai Lab Ltd Unsponsored American Deposit Receipt Repr 1 Sh